Straumann Holding Ag · SIX:STMN

Straumann — 9M 2016 Earnings Presentation

16 slides from Straumann's earnings presentation, Oct 27, 2016

  1. Slide 1: 2016 9-months sales presentation

    27.10.2016 2016 9-months sales presentation Webcast for investors, analysts & media Basel, 27 October 2016 1 Disclaimer This presentation contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties an

  2. Slide 2: Highlights

    27.10.2016 Highlights Marco Gadola, CEO Strong all-round performance continues in Q3 REVENUE GROWTH Q3 BUSINESSES STRONGEST REGIONS +12.5% Double-digit North America & in organic terms1 growth APAC +14.4% in CHF continues across all businesses; Entry into Argentina (2nd largest market Instradent pos

  3. Slide 3: A fourth consecutive quarter of double-digit growth

    27.10.2016 A fourth consecutive quarter of double-digit growth Organic revenue growth in % North America 28% of Group EMEA APAC 45% of Group 17% of Group 17.3 9.5 15.5 19.4 7.7 17.0 Q3 9M Q3 9M LATAM 10% of Group Q3 9M 14.5 Group 12.7 14.3 12.5 Q3 9M Q3 9M 5 Business and regional review Peter Hackel

  4. Slide 4: North America: strong expansion across all regions

    27.10.2016 Strong expansion across all regions Revenue development (in CHF million, rounded) 15.3% in CHF 13.2% organic 11% LATAM 8.9 18.1 25.3 23% APAC 26.4 5.4 5.7 North 32% America 675.1 585.3 596.4 Change in organic growth 34% EMEA 0.9% 1.0% 9.5% 15.5% 19.4% 14.5% Revenue 9M FX effect M&A effect

  5. Slide 5: APAC & LATAM keep the pace up

    27.10.2016 APAC & LATAM keep the pace up Revenue change (organic) 20.0% 21.0% 20.2%  Growth in Q3 exceeds market Asia Pacific 17.0% 12.8% 13.2% growth 17% 56%  Key performer: China  Chinese value segment entered - first full quarter of sales from Q2 Q3 Q4 Q1 Q2 Q3 Anthogyr 2016  Q3 revenue up 13

  6. Slide 6: Update on strategic progress

    27.10.2016 Update on strategic progress Marco Gadola, CEO Update on our strategic priorities Drive a high performance culture and organization Target unexploited growth markets & segments Become THE Total Solution Provider for Tooth Replacement 12 6

  7. Slide 7: Entry into Argentina; Instradent Europe now operational

    27.10.2016 Entry into LATAM’s 2nd largest market – Argentina  Subsidiary in Buenos Aires goes into operation and will address premium and non-premium segments  Distributor business taken over  Direct access to Argentinian market through own marketing, sales force, education, etc.  2nd largest ma

  8. Slide 8: Rapidly expanding footprint in the non-premium segment

    27.10.2016 Rapidly expanding footprint in the non-premium segment Neodent home market Instradent/Manohay footprint Medentika home market Instradent/Neodent distributors Equinox home market 15 Re-allocation in Europe to free up resources for emerging markets (effective 01.2017) Wolfgang Becker Jens D

  9. Slide 9: Production expansion to meet growing demand

    27.10.2016 Production expansion to meet growing demand Premium segment  Villeret (CH) & Andover (US) to increase output by a quarter in 2016/17 through capacity optimization and investments in plant & equipment Value segment  Curitiba (BR) will almost double capacity in coming years 17 Update on o

  10. Slide 10: Technology & manufacturing platform: update and further expansion

    27.10.2016 Steps initiated to become a ‘Total Solution Provider’ Diagnosis & Implant Regenerative Prosthetics treatment planning Standard & customized Tooth replacement Bone augmentation Membrane Soft tissue repair Accelerated treatment protocols Wound healing 3rd party prosthetics § Implant Enhance

  11. Slide 11: Straumann invests in V2R Biomedical; launches Novaloc

    27.10.2016 Straumann invests in V2R Biomedical – specialist in guided-surgery planning  Canadian company specialized in guided-surgery planning since 2008  30% stake acquired with option to increase to full ownership  ‘Smile-in-a-box’ concept to provide drill guide plus all components together fo

  12. Slide 12: New chairside system enters controlled market release

    27.10.2016 New chairside system enters controlled market release Straumann Amann Girrbach chairside mill  Market acceptance tests underway in Central Europe Straumann/Dental Wings intra-oral scanner  Attractively priced; launched in US (Benco and Burkhart)  Pilot in Germany; further test markets

  13. Slide 13: Planmeca adds distribution power for n!ce material

    27.10.2016 Planmeca adds distribution power for Straumann’s n!ce™ material  Unique glass ceramic for single-tooth restoration, optimized for chairside (‘mill-polish-seat’ concept; no crystallization firing required1)  Commercialization through all Straumann Group channels underway  Global distrib

  14. Slide 14: Outlook 2016

    27.10.2016 Outlook 2016 Guidance 2016 reiterated Barring unforeseen circumstances  Straumann expects the global implant market to grow solidly in 2016 and is confident that it can continue to outperform  Aims to achieve full-year organic growth in the low-double-digit range  Despite further inves

  15. Slide 15: Questions & answers

    27.10.2016 Questions & answers Calendar of upcoming events 2016 27 October Q3 revenue publication Webcast 02 November Vontobel Healthcare Tour Basel 15 November Investor meetings Zurich 17 November Credit Suisse Mid Cap Conference Zurich 08 December Credit Suisse European Healthcare Trip HQ, Basel 2

  16. Slide 16: Straumann's currency exposure

    27.10.2016 Straumann’s currency exposure Revenue breakdown FY20151 FX sensitivity Average exchange rates (rounded) CHF (+/- 10%) on full-year... Other 9% 2014 2015 9M 2016 Revenue EBIT 19% 1 EURCHF 1.21 1.08 1.09 +/- 26m +/- 16m 1 USDCHF 0.92 0.96 0.98 +/- 20m +/- 7m BRL EUR 10% 33% 1 BRLCHF 0.389 0

Straumann Group — 9M 2016 Earnings Presentation on 6ix